Search results for: 'android ed pl2c terminal forecast 2014'

09 Sep 2025  |  Global  |  Technology Research

Mixed Reality in Healthcare, Global, 2025–2029

Mixed Reality in Healthcare Is Driving Transformational Growth Through Medical Education, Emerging Growth Opportunities, Global Ecosystems, and Advanced Technology Analysis

Infographics

×

Mixed reality (MR) merges real and virtual elements to create interactive environments. Workforce shortages, rising training needs, patient engagement gaps, and the shift toward decentralized care are driving demand for immersive technologies in healthcare. By blending virtual and augmented reality, MR enables learners to practice complex clinical ...

Patients with neurological and psychiatric disorders often experience a low quality of life due to delays in diagnosis with traditional self-reporting and minimally invasive approaches. Despite medical innovations, the growing burden of neurological conditions remains a significant unmet need, calling for technologies that enable early diagnosis an...

26 Jan 2017  |  North America  |  Megatrends

The Future of the United States

The Social and Technological Forces Reshaping the Country

Infographics

×

Frost & Sullivan's research service on The Future of the United States offers a comprehensive analysis of the Mega Trends that will impact American citizens and businesses through 2025. In this research, Frost & Sullivan's expert analysts highlight the imminent challenges and opportunities for growth stemming from the following trends: Social, Hig...

According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...

This edition of the Trend Opportunity Profile Series explores trends in health, wellness, and nutrition, transforming patient care, offering better access to standard healthcare services. Innovations in AI-enabled hospital-at-home platforms and gamified healthcare solutions reflect high technology integration. This research focuses on other trends ...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, immersive technologies, and diagnostics industry. The issue includes advanced medical devices such as implant to treat severe emphysema, platform for developing 3D models for surgical planning, point-of-ca...

19 Apr 2017  |  Asia Pacific  |  Market Research

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

Infographics

×

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

29 Jan 2016  |  Africa  |  Market Research

Ethiopian Pharmaceutical Market, Forecast to 2020

Preference for Generic Prescription Drugs to Create New Market Dynamics, Demand for Anti-Infectives Rises

Infographics

×

This study offers an insight into the pharmaceutical industry of Ethiopia, where preference for generic, prescription drugs is growing. There is information on recent reforms introduced by the government (like tax benefits for in-country production, national strategy, and plan of action for pharmaceutical manufacturing development, growth and trans...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...